A biotech company dedicated to the discovery and development of protein therapeutics using its proprietary alphabody™ technology. Alphabodies are robust and versatile protein scaffolds, unrelated to immunoglobulins, and inspired by naturally occurring motives. Complix’s proprietary Cell Penetrating Alphabody (CPAB) technology allows it to access a broad range of intracellular disease related targets that are considered “intractable” by currently available drug formats, such as antibodies and small molecules.
Company Details
- Employees
- 7
- Founded
- 2008
- Address
- Agoralaan A-Bis, Diepenbeek,3590,belgium
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- complix.com
- Keywords
- Biopharmaceuticals.
- HQ
- Diepenbeek
Complix N.v. Questions
Complix N.V.'s website is complix.com
Complix N.V.'s LinkedIn profile is https://be.linkedin.com/company/complix
Complix N.V. has
7 employees.
View email and phone details for 7
employees at Complix N.V..
Complix N.V.'s industry is
Biotechnology Research
Complix N.V.'s top competitors are
Legend Biotech,
Exevir,
Ablynx,
Agomab,
Flamingo Therapeutics,
Etherna,
Montis Biosciences,
Biocartis,
Confo Therapeutics,
Rewind Therapeutics.
Complix N.V.'s categories are Biotechnology Research
Complix N.V.'s founding year is 2008
